Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The company’s portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, and adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs its drug delivery systems to advance drug compounds and drug delivery methods. It also advances various product development programs in partnership with various leading pharmaceutical companies including Teva and AMAG. The company has a presence in the US and Switzerland. Antares Pharma is headquartered in Ewing, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
Reasons to buy
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Antares Pharma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Antares Pharma Inc Company Overview
- Antares Pharma Inc Company Snapshot
- Antares Pharma Inc Pipeline Products and Ongoing Clinical Trials Overview
- Antares Pharma Inc - Pipeline Analysis Overview
- Business Description
- Antares Pharma Inc - Key Facts
- Antares Pharma Inc - Major Products and Services
- Antares Pharma Inc Pipeline Products by Development Stage
- Antares Pharma Inc Pipeline Products Overview
- Teva Pen 1
- Teva Pen 1 Product Overview
- Vibex EPI
- Vibex EPI Product Overview
- Vibex QS M
- Vibex QS M Product Overview
- Antares Pharma Inc - Key Competitors
- Antares Pharma Inc - Key Employees
- Antares Pharma Inc - Key Employee Biographies
- Antares Pharma Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Antares Pharma Inc, Recent Developments
- May 30, 2018: Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET Needle-Free Delivery System
- May 08, 2018: Antares Pharma Reports First Quarter 2018 Operating and Financial Results
- Mar 27, 2018: Antares Pharma Provides XYOSTED Regulatory Update
- Mar 01, 2018: Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet Needle-Free Delivery System
- Feb 14, 2018: Antares Pharma Announces FDA Approval of Partners Product Utilizing Our QuickShot Auto Injector
- Jan 31, 2018: Ferring's ZOMACTON (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults
- Jan 16, 2018: Antares Pharma Provides XYOSTED Regulatory Update
- Nov 07, 2017: Antares Pharma Reports Third Quarter 2017 Operating and Financial Results
- Oct 12, 2017: Antares Pharma Provides Xyosted Regulatory Update
- Aug 08, 2017: Antares Pharma Reports Second Quarter 2017 Operating And Financial Results
- Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Antares Pharma Inc Pipeline Products and Ongoing Clinical Trials Overview
- Antares Pharma Inc Pipeline Products by Equipment Type
- Antares Pharma Inc Pipeline Products by Indication
- Antares Pharma Inc, Key Facts
- Antares Pharma Inc, Major Products and Services
- Antares Pharma Inc Number of Pipeline Products by Development Stage
- Antares Pharma Inc Pipeline Products Summary by Development Stage
- Teva Pen 1 - Product Status
- Teva Pen 1 - Product Description
- Vibex EPI - Product Status
- Vibex EPI - Product Description
- Vibex QS M - Product Status
- Vibex QS M - Product Description
- Antares Pharma Inc, Key Employees
- Antares Pharma Inc, Key Employee Biographies
- Antares Pharma Inc, Other Locations
- Antares Pharma Inc, Subsidiaries
- Glossary
List of Figures
- Antares Pharma Inc Pipeline Products by Equipment Type
- Antares Pharma Inc Pipeline Products by Development Stage
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teva Pharmaceutical Industries Ltd
- Sandoz Inc
- Mylan NV
- Medac Pharma Inc
- Lipocine Inc
- Hospira Inc
- Endo Pharmaceuticals Inc
- Eli Lilly and Company Ltd
- Clarus Therapeutics Inc
- Allergan Plc
- Acerus Pharmaceuticals Corp
- Accord Healthcare Inc
- AbbVie Inc
